[1] Carlomagno, G., Unfer, V., & Roseff, S. (2011). The D-chiro-inositol paradox in the ovary. Fertility and Sterility, 95(8), 2515-2516. DOI: 10.1016/j.fertnstert.2011.05.027 
https://pubmed.ncbi.nlm.nih.gov/21641593/

[2] Caprio, F., D’Eufemia, M.D., Trotta, C., Campitiello, M.R., Ianniello, R., Mele, D., & Colacurci, N. (2015). Myo-inositol therapy for poor-responders during IVF: a prospective controlled observational trial. Journal of Ovarian Research, 8. DOI: 10.1186/s13048-015-0167-x 
https://pubmed.ncbi.nlm.nih.gov/26067283/

[3] Reproductive Science Center. (2015, August 14). Myo-inositol for fertility treatment. https://rscbayarea.com/integrative-medicine-blog/myo-inositol-for-fertility-treatment

[4] Colazingari, S., Treglia, M., Najjar, R., & Bevilacqua, A. (2013). The combined therapy myo-inositol plus d-chiro-inositol, rather than d-chiro-inositol, is able to improve IVF outcomes: results from a randomized controlled trial. Archives of Gynecology and Obstetrics, 288, 1405-1411. 
https://doi.org/10.1007/s00404-013-2855-3

[5] 2023 Jan 26;21(1):10. doi: 10.1186/s12958-023-01055-z.
Inositol is an effective and safe treatment in polycystic ovary syndrome: a systematic review and meta-analysis of randomized controlled trials
Dorina Greff 1 2 3, Anna E Juhász 1 4, Szilárd Váncsa 1 5 6, Alex Váradi 5, Zoltán Sipos 5, Julia Szinte 1 2 3, Sunjune Park 1 3, Péter Hegyi 1 5 6, Péter Nyirády 7, Nándor Ács 2, Szabolcs Várbíró 8 9, Eszter M Horváth 3
https://pubmed.ncbi.nlm.nih.gov/36703143/

[6] Ijuin T, Takenawa T. Regulation of insulin signaling and glucose transporter 4 (GLUT4) exocytosis by phosphatidylinositol 3,4,5-trisphosphate (PIP3) phosphatase, skeletal muscle, and kidney enriched inositol polyphosphate phosphatase (SKIP) J Biol Chem. 2012;287(10):6991–6999. doi: 10.1074/jbc.M111.335539. [PMC free article] [PubMed] [CrossRef] [Google Scholar] [Ref list]
https://pubmed.ncbi.nlm.nih.gov/22247557/

[7] Medicine (Baltimore) 2017 Dec;96(49):e8842. doi: 10.1097/MD.0000000000008842.Inositol supplement improves clinical pregnancy rate in infertile women undergoing ovulation induction for ICSI or IVF-ET Xiangqin Zheng 1, Danmei Lin, Yulong Zhang, Yuan Lin, Jianrong Song, Suyu Li, Yan Sun
https://pubmed.ncbi.nlm.nih.gov/29245250/

[8] Fariba Seyedoshohadaei 1 2, Shahin Abbasi 1, Masoumeh Rezaie 1 2, Azra Allahvaisi 2 3, Mohammad Jafar Rezaie 2 3, Nasrin Soufizadeh 1, Khaled Rahmani 4. Myo-inositol effect on pregnancy outcomes in infertile women undergoing in vitro fertilization/intracytoplasmic sperm injection: A double-blind RCT. Int J Reprod Biomed
. 2022 Sep 6;20(8):643-650. doi: 10.18502/ijrm.v20i8.11753. eCollection 2022 Aug.
Affiliations expand
https://pubmed.ncbi.nlm.nih.gov/36313255/

[9]Mariano Bizzarri 1 2, Noemi Monti 1, Aurora Piombarolo 1, Antonio Angeloni 1, Roberto Verna 2 Myo-Inositol and D-Chiro-Inositol as Modulators of Ovary Steroidogenesis: A Narrative Review. Affiliations expand
PMID: 37111094 PMCID: PMC10145676 DOI:10.3390/nu150818753
https://pubmed.ncbi.nlm.nih.gov/37111094/

[10] Costanzo Moretti 1, Marco Bonomi 2 3, Paola Dionese 4, Silvia Federici 2 3, Anna Maria Fulghesu 5, Jacopo Giannelli 6, Roberta Giordano 7, Laura Guccione 1, Elisa Maseroli 8, Paolo Moghetti 9, Roberto Mioni 10, Rosario Pivonello 11, Chiara Sabbadin 12, Carla Scaroni 12, Massimo Tonacchera 13, Nunzia Verde 14, Linda Vignozzi 8, Alessandra Gambineri 15. Inositols and female reproduction disorders: a consensus statement from the working group of the Club of the Italian Society of Endocrinology (SIE)-Women’s Endocrinology. Endocrinology
PMID: 39009925 DOI: 10.1007/s40618-024-02363-w
https://pubmed.ncbi.nlm.nih.gov/39009925/